2.2  Measures
Demographic details were recorded as described in other reports (Titov et al., 2015; Titov et al., 2017; Titov et al., submitted for publication). The symptom measures were scores on the K-10, a measure of psychological distress (Kessler et al., 2002), the GAD7 measuring generalized anxiety (Kroenke et al., 2001), and the PHQ9 measuring symptoms of depression (Spitzer et al., 2006). Patients also answered questions about how long they thought they had symptoms of anxiety or depression. All patients answered questions about suicidal ideation, plans and intent as described previously (Nielssen et al., 2015). On 19 March 2020, several additional questions about the impact of COVID-19 were added to the MindSpot assessment. MindSpot therapists were also asked about the concerns raised by patients, in order to develop guidelines to assist MindSpot therapists in addressing those concerns. Information about those concerns was derived from an examination of 50 written case summaries prepared by therapists answering telephone calls, completing assessments or providing treatment.